Pulmonary thromboembolism (PTE) is the major cause of maternal death in the
UK, with recent trends showing an increase in the numbers of deaths. Under
lying PTE is the problem of deep venous thrombosis (DVT). An appreciation o
f risk factors, particularly, thrombophilia, and signs or symptoms suggesti
ve of thromboembolism, coupled with objective diagnosis and treatment shoul
d reduce mortality and morbidity. There are particular considerations with
regard to the management of thrombosis in pregnancy, especially the use of
anticoagulants. Low-molecular-weight heparins are now replacing unfractiona
ted heparin for the treatment of DVT and PTE in pregnancy.